Skip to content

Ivermectin

Sklice, Soolantra, Stromectol, Mectizan (ivermectin) is an unknown pharmaceutical. Ivermectin was first approved as Sklice on 1996-11-22. It is used to treat ascariasis, elephantiasis, enterobiasis, lice infestations, and mansonelliasis amongst others in the USA. It is known to target P2X purinoceptor 4, neuronal acetylcholine receptor subunit alpha-7, P2X purinoceptor 7, and gamma-aminobutyric acid receptor subunit beta-3. Stromectol's patents are valid until 2034-03-13 (FDA).
Trade Name Mectizan
Common Name Ivermectin
ChEMBL ID CHEMBL1200633
Indication ascariasis, elephantiasis, enterobiasis, lice infestations, mansonelliasis, onchocerciasis, scabies, strongyloidiasis, trichuriasis
Drug Class Antiparasitics (ivermectin type)
Ivermectin
Get full access now